Novartis finds no evidence of wrongdoing in clinical trials
Japan | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013
Singapore: Novartis Pharma KK has found no evidence that data on clinical trials for its hypertension drug Diovan had be...Read more
Protein A chromatography resin for purification of antibody drugs
Japan | News | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2012
Singapore: Kaneka launched KanCapA, a new protein A chromatography resin for the purification of therapeutic antibodies...Read more
Eisai seeks approval for antiepileptic agent in Japan
Japan | Regulatory | By BioSpectrum Bureau | 1 Comment | 31 Aug, 2012
Singapore: Eisai has submitted a marketing authorization application to Japan's Ministry of Health, Labor and Welfare (M...Read more
Debiopharm awards Japanese cancer scientists
Japan | News | By BioSpectrum Bureau | 0 Comment | 24 Sep, 2012
Singapore: Debiopharm Group presented the 'JCA-Mauvernay Award' to Dr Masanobu Oshima from Kanazawa University, Japan, ...Read more
Japanese food giant to buy GSK drinks for $2.35 bn
Japan | News | By BioSpectrum Bureau | 0 Comment | 09 Sep, 2013
Singapore: Sky News has reported that GlaxoSmithKline (GSK) is in talks with Japanese firm Suntory to sell its drugs Luc...Read more
Boston Strategics gets rights for Eisai's cancer drug
Japan | News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2014
Singapore: Boston Strategics Corp (BSC), a clinical-stage drug research and development (R&D) company has signed an ...Read more
Dehaier signs deal with Beijing Kanglian Medicine
Japan | News | By BioSpectrum Bureau | 0 Comment | 14 Dec, 2012
Singapore: Dehaier Medical has obtained a medical equipment procurement agreement valued at approximately $320,580 (RMB...Read more
Otsuka, Abdi Ä°brahim start joint venture in Turkey
Japan | News | By BioSpectrum Bureau | 0 Comment | 16 Nov, 2012
Singapore: Japan-headquartered Otsuka Pharmaceutical and Turkish firm Abdi Ibrahim have established a joint venture, Abd...Read more
F&S: Personalization is the new mantra in healthcare
Japan | Analysis | By BioSpectrum Bureau | 0 Comment | 14 May, 2013
Singapore: Frost & Sullivan partner Ms Reenita Das during her keynote presentation at the 12th International BIOtech...Read more
Nexium gets nod in Japan for gastric ulcer
Japan | Regulatory | By BioSpectrum Bureau | 0 Comment | 25 Jun, 2012
Singapore: AstraZeneca has received approval from the Japanese Ministry of Health, Labour and Welfare for a supplemental...Read more
Eisai's UK manufacturing plant gets EU license
Japan | News | By BioSpectrum Bureau | 0 Comment | 27 Sep, 2012
Singapore: Japan-headquartered Eisai's UK manufacturing subsidiary Eisai Manufacturing, situated within the company's Eu...Read more
Snoasis initiates distribution in Japan through Hausten Healthcare
Japan | News | By BioSpectrum Bureau | 0 Comment | 30 Jul, 2012
Singapore: Snoasis Medical has signed a distribution agreement with Hausten Healthcare, whereby Hausten Healthcare will ...Read more
Terumo completes patient enrollment in the US for trial
Japan | News | By BioSpectrum Bureau | 0 Comment | 12 Jul, 2012
Singapore: Terumo Interventional Systems, a strategic business unit of Terumo Medical Corporation, a US subsidiary of To...Read more
Furiex, Menarini sign agreement for Priligy
Japan | News | By BioSpectrum Bureau | 0 Comment | 15 May, 2012
Singapore: Furiex Pharmaceuticals and Menarini Group have signed an agreement giving Menarini rights to commercialize Pr...Read more
Human Metabolome Technologies opens US office
Japan | News | By BioSpectrum Bureau | 0 Comment | 09 Nov, 2012
Singapore: Human Metabolome Technologies, a Japanese company that deals in capillary electrophoresis mass spectrometry (...Read more
Response Genetics renews deal with Taiho Pharma
Japan | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2013
Singapore: US-based Response Genetics, a company focused on the development and sale of molecular diagnostic tests that ...Read more
Eisai pulls drug from Germany due to unsuitable policies
Japan | Regulatory | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2013
Singapore: Eisai suspended sales of its epilepsy drug Fycompa (perampanel) in Germany due to unfavorable conditions set ...Read more
Daiichi, ArQule cancer trial fails to meet endpoint
Japan | News | By BioSpectrum Bureau | 0 Comment | 14 Jan, 2013
Singapore: Daiichi Sankyo Company and ArQule announced the top-line results of a randomized phase II signal generation ...Read more